Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy

International Journal of Antimicrobial Agents

Volumn 41, Issue 3, 2013, Pages 261-266

  Covajes, Cecilia ^a   Scolletta, Sabino ^a   Penaccini, Laura ^a   Ocampos Martinez, Eva ^a   Abdelhadii, Ali ^a   Beumier, Marjorie ^a   Jacobs, Frédérique ^a   De Backer, Daniel ^a   Vincent, Jean Louis ^a   Taccone, Fabio Silvio ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Continuous infusion; Continuous renal replacement therapy; Pharmacokinetic; Renal failure; Sepsis; Vancomycin

Indexed keywords

HYPERTENSIVE FACTOR; VANCOMYCIN;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SEPSIS; SERUM; VANCOMYCIN;

EID: 84872901678     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.10.018     Document Type: Article

References (29)

1. M.J. Rybak, B.M. Lomaestro, J.C. Rotschafer, R.C. Moellering, W.A. Craig, and M. Billeter Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 2009 325 327
2. S.J. van Hal, T.P. Lodise, and D.L. Paterson The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis Clin Infect Dis 54 2012 755 771
3. M. Cruciani, G. Gatti, L. Lazzarini, G. Furlan, G. Broccali, and M. Malena Penetration of vancomycin into human lung tissue J Antimicrob Chemother 38 1996 865 869 (Pubitemid 26413723)
4. C. Aubron, C.E. Corallo, M.O. Nunn, M.J. Dooley, and A.C. Cheng Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients Ann Pharmacother 45 2011 1193 1198
5. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
6. A.E. Patanwala, C.J. Norris, D.E. Nix, B.J. Kopp, and B.L. Erstad Vancomycin dosing for pneumonia in critically ill trauma patients J Trauma 67 2009 802 804
7. M. Wysocki, F. Delatour, F. Faurisson, A. Rauss, Y. Pean, and B. Misset Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study Antimicrob Agents Chemother 45 2001 2460 2467 (Pubitemid 32801896)
8. S.J. Vandecasteele, and A.S. De Vriese Recent changes in vancomycin use in renal failure Kidney Int 77 2010 760 764
9. E.A. Hoste, and A. Dhondt Clinical review: use of renal replacement therapies in special groups of ICU patients Crit Care 16 2012 201
10. F.P. Wilson, and J.S. Berns Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD) Clin Nephrol 77 2012 329 331
11. M.S. Joy, G.R. Matzke, R.F. Frye, and P.M. Palevsky Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis Am J Kidney Dis 31 1998 1019 1027 (Pubitemid 28265200)
12. C. Santre, O. Leroy, M. Simon, H. Georges, B. Guery, and C. Beuscart Pharmacokinetics of vancomycin during continuous hemodiafiltration Intensive Care Med 19 1993 347 350 (Pubitemid 23284799)
13. W. Chaijamorn, A. Jitsurong, K. Wiwattanawongsa, U. Wanakamanee, and P. Dandecha Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients Int J Antimicrob Agents 38 2011 152 156
14. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook SCCM/ESICM/ACCP/ATS/SI.S. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256 (Pubitemid 36444440)
15. E. Ocampos-Martinez, L. Penaccini, S. Scolletta, A. Abdelhadii, A. Devigili, and S. Cianferoni Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients Int J Antimicrob Agents 39 2012 332 337
16. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829 (Pubitemid 15250137)
17. J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonca, and H. Bruining The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
18. S.J. Vandecasteele, and A.S. De Vriese Vancomycin dosing in patients on intermittent hemodialysis Semin Dial 24 2011 50 55
19. T.A. Pollard, V. Lampasona, S. Akkerman, K. Tom, M.A. Hooks, and R.E. Mullins Vancomycin redistribution: dosing recommendations following high-flux hemodialysis Kidney Int 45 1994 232 237 (Pubitemid 24046013)
20. L.M. van de Vijsel, S.A. Walker, S.E. Walker, S. Yamashita, A. Simor, and M. Hladunewich Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis Can J Hosp Pharm 63 2010 196 206
21. M. del Mar Fernández de Gatta Garcia, N. Revilla, M.V. Calvo, A. Domínguez-Gil, and A. Sánchez Navarro Pharmacokinetic/ pharmacodynamic analysis of vancomycin in ICU patients Intensive Care Med 33 2007 279 285 (Pubitemid 46221233)
22. F. Pea, L. Porreca, M. Baraldo, and M. Furlanut High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures J Antimicrob Chemother 45 2000 329 335 (Pubitemid 30139241)
23. W.L. Macias, B.A. Mueller, and S.K. Scarim Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance Clin Pharmacol Ther 50 1991 688 694
24. F.T. Boereboom, F.F. Ververs, P.J. Blankestijn, T.J. Savelkoul, and A. van Dijk Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients Intensive Care Med 25 1999 1100 1104 (Pubitemid 29525065)
25. M.E. DelDot, J. Lipman, and S.E. Tett Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration Br J Clin Pharmacol 58 2004 259 268 (Pubitemid 39209059)
26. M. Valtonen, E. Tiula, O. Takkunen, J.T. Backman, and P.J. Neuvonen Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure J Antimicrob Chemother 48 2001 881 885 (Pubitemid 33735325)
27. D.M. Roberts, J.A. Roberts, M.S. Roberts, X. Liu, P. Nair, and L. Cole Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicenter pharmacokinetic study Crit Care Med 40 2012 1523 1528
28. L. Seyler, F. Cotton, F.S. Taccone, D. De Backer, P. Macours, and J.L. Vincent Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy Crit Care 15 2011 R137
29. K. Berthoin, E. Ampe, P.M. Tulkens, and S. Carryn Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections Int J Antimicrob Agents 34 2009 555 560